CLL EQAs now open for registration

2020 Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status (pilot): click HERE 

2020 Chronic Lymphocytic Leukaemia (CLL) TP53 mutation analysis (pilot): click HERE 

GenQA and UK NEQAS LI are pleased to announce that they will be working together with the ERIC (European Research Initiative on CLL) TP53 and IG networks to assure the quality of TP53 and IG testing in patients with CLL.

ERIC will continue to work with laboratories to achieve accuracy of testing through their initial certification process whilst GenQA and UK NEQAS LI will assure the maintenance of competency of previously certified laboratories by providing an external quality assessment scheme (EQA). Both the certification and the EQA procedures will follow the same assessment process adhering to ERIC recommendations for analysis and interpretation of TP53 and IG testing.

These pilot-EQAs are aimed at laboratories that are ERIC certified for TP53 and/or IGH testing so, if you are not yet certified, please refer to to learn more on how to participate in a round to obtain the initial certification. Prior participation in ERIC certification enables laboratories that have recently introduced TP53 or IG analyses, or those that have recently introduced new technologies, to benefit from the advice and reassurance on the accuracy of testing that the ERIC network provides before participation in EQA.

Non ERIC certified laboratories
To register for ERIC certification go to:
For further information

Certified laboratories
If you are not already a member of GenQA please go to: GenQA registration page.  Once registered, you will be sent login details to enrol in these EQAs.
If you are already a GenQA member then please login with your GenQA participant identifier to enrol in these EQAs.

For further information contact:





Last updated: Monday, 15 June 2020
Go to top